Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.
about
Biologically active substances-enriched diet regulates gonadotrope cell activation pathway in liver of adult and old rats.Carotenoids and non-alcoholic fatty liver disease.Elevated ratio of arachidonic acid to long-chain omega-3 fatty acids predicts depression development following interferon-alpha treatment: relationship with interleukin-6.n-3 polyunsaturated fatty acid supplementation reduces insulin resistance in hepatitis C virus infected patients: a randomised controlled trial.
P2860
Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.
@ast
Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.
@en
Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.
@nl
type
label
Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.
@ast
Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.
@en
Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.
@nl
prefLabel
Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.
@ast
Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.
@en
Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.
@nl
P2860
P356
P1433
P1476
Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.
@en
P2093
P2860
P2888
P356
10.1186/1471-230X-10-49
P5008
P577
2010-05-20T00:00:00Z
P6179
1049368517